Mice Model Market

Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (CRISPR, Microinjection), Application (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2021

Report Code: BT 2192 Feb, 2017, by marketsandmarkets.com

[269 Pages Report] MarketsandMarkets forecasts the mice model market to grow from USD 1.11 billion in 2016 to USD 1.59 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period. The growth of the market can be attributed to ongoing innovations in mice models, continuous support in the form of investments and grants, and growing demand for humanized mice models. The objective of the report is to define, describe, and forecast the mice model market size based on type, technology, application, and service and region.

Mice Model Market

By type, the genetically engineered mice segment to witness the highest growth during the forecast period (2016–2021).

Based on type, the mice model market is segmented into inbred, outbred, conditioned/surgically modified, hybrid/congenic, genetically engineered, and spontaneous mutant mice models. the genetically engineered mice model segment is expected to be the fastest-growing market. Growth in this market is mainly driven by factors such as the emergence of CRISPR technology which helps generating gene knockouts; regular investments in the development of new and innovative knockout models that also increases the application areas of these models.

By Service, the breeding services segment to account for the largest share of the global mice model market in 2016

Based on service, the market is segmented into breeding, quarantine, cryopreservation, rederivation, genetic testing, model in-licensing, and other services (surgical, line rescue, and in vivo pharmacology services). The breeding services segment is expected to account for the largest share of the global mice model market in 2016. The large share of this segment can be attributed to the growing need for expertise in breeding mutant, transgenic, gene-targeted, and other types of mice, resulting in growth in demand for breeding services amongst biomedical and pharmaceutical researchers.

By Technology, the CRISPR technology segment to account for the largest share of the global mice model market in 2016

Based on technology, the market is segmented into CRISPR/Cas9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies. The CRISPR technology accounts for the largest share of the global mice model market in 2016. The large share of this segment can primarily be attributed to the fact that CRISPR is the most widely used technique due to the various advantages associated with it, such as ease of design, high efficiency, and relatively low cost.

By Application, the oncology studies segment to account for the largest share in 2016 and to witness the highest growth rate during the forecast period (2016-2021)

Based on application, the market is segmented into oncology studies, immunology and inflammation studies, central nervous system studies (anxiety and other disorders), cardiovascular studies, diabetes studies, and other disease studies. In 2016, the oncology studies segment is expected to command the largest share of the global mice model market, by application. The high growth and large market share in this segment can be attributed to the growing cancer research activities and increasing innovation in mice models that are tailored to meet cancer research needs.

By Mice care products by type, the cage segment to account for the largest share in 2016

Based on care products by type, the market is segmented into bedding, cages, feed, and other products. The cages segment accounted for the largest share of the global mice care products market, by type, in 2016. The large share of this segment can be attributed to the higher cost of cages as compared to other care products.

Mice Model Market

North America to account for the largest market size during the forecast period.

North America is accounted for the largest share of the market. North America’s leadership in the market can be attributed to the increased focus on biomedical research in the U.S., rising demands for monoclonal antibody production, nexus between CRO’s and pharmaceutical companies, continued and responsible use of animals ensured by animal care organizations, rising preclinical activities by CROs and pharmaceutical companies, and growing stem cell research in Canada.

Asia Pacific is the third-largest market for mice model market and is slated to register the highest CAGR of 7.9% during the forecast period. The high growth in the region can be attributed to less stringent regulations on the use of animal models for research in the region, international alliances for R&D activities in China, growth in regenerative medicine, biomedical, and medical research in Japan, growing presence of global players, development of bioclusters to boost the biotechnology industry in India, ongoing biomedical research activities in Australia, and rising pharmaceutical & biotechnology R&D activities.

Market Dynamics

Driver: Ongoing innovations in mice models

Globally, continuous research is being undertaken to develop treatments for various chronic, acute, and rare diseases. The majority of these research activities are highly dependent on animal models. Thus, market players are continuously focusing on innovations in mice models for research on various human diseases. Mentioned below are some of the recent developments in mice models.

  • Mice models for immune diseases - In February 2016, The Jackson Laboratory expanded access to the NSG-SGM3 mouse model to scientists worldwide. This move is expected to accelerate research in immuno-oncology, immunology, and infectious diseases. Moreover, in February 2016, Taconic Biosciences launched the huNOG-EXL, an extended lineage mice model, with an aim to improve immuno-oncology, allergy, and inflammation research. Similarly, since August 2015, Jackson Laboratory, in collaboration with a professor from Yale University, is working on the investigation and validation of a humanized MISTRG model for studying immune-mediated mechanisms of tumorigenesis.
  • Mice model for cancer - In April 2015, Trans Genic, Inc. launched three strains of new model mice, which included a breast cancer model mouse—cathepsin E knockout mouse. In April 2015, The Jackson Laboratory, in collaboration with the Seoul National University (South Korea), received a five-year, USD 7.5 million grant from the South Korean government. The grant was provided for a large-scale cancer genomics project employing the latest sequencing technology and special JAX mouse models that can host human tumors.
  • Mice model for rare disease - The development of mice models for rare diseases has witnessed significant developments in recent years. The Jackson Laboratory is regularly working on developing mice models for various rare disorders like inherited peripheral neuropathies and neurodegenerative diseases, including Charcot-Marie-Tooth disease (CMT). Similarly, Taconic Biosciences (U.S.) is working on the development and breeding of a custom mouse model in order to study Vici Syndrome. This syndrome is a rare, severe congenital multisystem disorder characterized by a failure to develop the corpus callosum region of the brain along with cardiomyopathy; cataracts; hypopigmentation of the skin, eyes, and hair; and combined immunodeficiency.

Restrain: Growing usage of rat model

Advancements in genetic techniques for the development of genetically modified rats have driven the adoption of rats as models for human diseases. The increased availability of knockout rats, mutant rats, as well as embryonic stem cell lines makes them preferred animals for studying various human diseases.Rats serve as better disease models for cardiovascular disease, diabetes, breast cancer, neurological diseases, and other diseases as compared to mice. Some of the advantages offered by rat models over mice models are listed below:

  • The embryonic stem cell technology, traditionally used to generate genetically modified mice, takes about a year. In contrast, knockout rat models can be efficiently generated in about 6 months using advanced gene editing technologies. Zinc finger nucleases are injected directly into fertilized embryos, eliminating the need for ES cells and removing species limitations.
  • Mice are less robust and reliable on behavioral assays as compared to rats due to their small size.
  • Rats outperform mice on assays of learning, memory, and addiction.
  • In pain assays, rats are less susceptible to anxiety-induced analgesia and are more reliable. Hence, traditionally, rats were preferred over mice in pain-related studies.
  • The liver metabolism of rats (in terms of the number and type of liver enzymes) is more similar to humans.
  • It is easy to surgically modify rats and collect samples; hence, rats are preferred over mice for many adsorption, distribution, metabolism, excretion, and toxicity (ADMET) studies.

These advantages are triggering the preference for rat models over mice models among researchers. This trend is expected to gain momentum in the coming years, thus restraining the growth of the mice model market.

Opportunity: Emergence of CRISPR as a powerful tool in the field of biomedical research

CRISPR (clustered, regularly interspaced, short palindromic repeat) is seen as a revolutionary technology for gene editing. The use of Cas9 enzyme differentiates CRISPR from other forms of genetic modification. This technology edits and rearranges genes by cutting out damaged or unwanted parts of the DNA, allowing the remaining DNA to be rearranged in a new way. Moreover, this fast, precise, and easy-to-use technology is considered as a revolutionary tool in research, and there is an intense interest to validate its therapeutic usage in humans. CRISPR was first shown to work in mouse and human cells less than three years ago and has already been applied to a range of biological systems and disease areas. CRISPR is used in the development of genetically modified mice strains, making the process not only quicker but also less expensive. Thus, the emergence of CRISPR as a popular technology is expected to offer potential growth opportunities in the coming years.

Scope of the Report

Report Metric

Details

Market size available for years

2014–2021

Base year considered

2015

Forecast period

2016–2021

Forecast units

Million (USD)

Segments covered

Type (Inbred, Outbred, Genetically Engineered, Conditioned/Surgically Modified, Hybrid/Congenic, and Spontaneous Mutant Mice), Service (Breeding, Quarantine, Cryopreservation, Rederivation, Genetic testing, Model in-Licensing, and Other services), Technology (CRISPR/Cas9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies), Application (oncology studies, immunology and inflammation studies, central nervous system studies (anxiety and other disorders), cardiovascular studies, diabetes studies, and other disease studies), and Mice care products by type (bedding, cages, feed, and other products), and Region

Geographies covered

North America, Europe, APAC, and Rest of the World

Companies covered

Charles River Laboratories, International, Inc. (U.S.), The Jackson Laboratory (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (Harlan Laboratories, Inc.) (U.K.), Laboratory Corporation of America Holdings (U.S.), Janvier Labs (France), Trans Genic, Inc. (Japan), Genoway (France), Horizon Discovery Group (UK), and Ingenious Targeting Laboratory (US).

The research report categorizes the mice model market to forecast the revenues and analyze the trends in each of the following sub-segments:

Mice Model Market

Mice Model Market, by Type

  • Inbred Mice
  • Genetically Engineered Mice
  • Conditioned/Surgically Modified Mice
  • Hybrid/Congenic Mice
  • Outbred Mice
  • Spontaneous Mutant Mice

Mice Model Market, by Technology

  • CRISPR
  • Microinjection
  • Embryonic Stem Cell Injection
  • Nuclear Transfer
  • Other Technologies (Genetically modified sperm-mediated Gene Transfer, Virus/Vector-mediated Gene Transfer, Liposome-mediated DNA & Electroporation of DNA, Biolistics, and TALENs & ZFN)

Mice Model Market, by Application

  • Oncology Studies
  • Immunology and Inflammation Studies
  • Diabetes Studies
  • Cardiovascular Studies
  • Central Nervous System Studies
  • Other Disease Studies (Rare Diseases, Renal Disorders, Haematopoiesis, Toxicology, among others)

Mice Model Market, by Service

  • Breeding Services
  • Cryopreservation
  • Quarantine
  • Rederivation
  • Genetic Testing
  • Model in licensing
  • Other Services (Surgical, Line Rescue, In Vivo Pharmacology Services)

Mice Care Products Market, by Type

  • Bedding
  • Cages
  • Feed
  • Other Care Products (Gnotobiotic Equipment, Water Systems, Accessories)

*Note: Accessories include washing systems, logistics, water purification systems, and sound absorption panels.

Mice Model Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe (RoE)
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of APAC
    • Rest of the World (RoW)

Key Market Players

Charles River Laboratories International, Inc. (U.S.), The Jackson Laboratory (U.S.), Taconic Biosciences, Inc. (U.S.), TRANS GENIC Inc. (Japan), Horizon Discovery Group plc (U.S.), Envigo (U.K.), Laboratory Corporation of America Holdings (U.S.), and genOway (France).

Charles River Laboratories is a leading player in the global mice models and services market. The mice models offered by the company include inbred, outbred, hybrid, immunodeficient, congenic, and genetically engineered mice. The company also offers mice modeling services such as surgical services for rodents, genetic testing services, colony management services, and health monitoring services. The strong portfolio enables the company to increase collaboration with clients—from early lead generation to candidate selection.

Recent Developments

  • In 2019, Taconic Biosciences launched ARTE10 alzheimers disease mouse model
  • In 2018, Charles River entered into a collaborative agreement with genOway inorder to access it customers with 2,000 ready-to-use knockout mouse models.
  • In 2018, Taconic Biosciences and Cyagen Biosciences entered into a strategic partnership. Under this partnership, the two companies will combine resources to provide the global scientific community with access to premium custom model design and generation services

Critical questions the report answers:

  • Where will all these developments take the industry in the long term?
  • What are the upcoming trends for the mice model market?
  • Which segment provides the most opportunity for growth?
  • Who are the leading vendors operating in this market?
  • What are the opportunities for new market entrants?

Available customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Industry Insights
                    2.2.2.2 Key Data From Primary Sources
                    2.2.2.3 Key Insights From Primary Sources
    2.3 Market Size Estimation Methodology
    2.4 Market Data Validation and Triangulation
    2.5 Assumptions

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Ongoing Innovations in Mice Models
                               5.2.1.1.1 Mice Models for Immune Diseases
                               5.2.1.1.2 Mice Models for Cancer
                               5.2.1.1.3 Mice Models for Rare Diseases
                    5.2.1.2 Growing Consumption of Personalized Medicine Driving the Demand for Humanized Mice Models
                    5.2.1.3 Continuous Support in the Form of Grants and Investments
                    5.2.1.4 Growing Number of Pharmaceutical R&D Activities
                    5.2.1.5 Increasing Focus of Associations on the Development of Embryonic Stem Cells as Well as Knockout and Mutant Mice
                               5.2.1.5.1 International Mouse Phenotyping Consortium (IMPC)
                               5.2.1.5.2 International Knockout Mouse Consortium (IKMC)
           5.2.2 Restraints
                    5.2.2.1 Growing use of Rat Models
                    5.2.2.2 Increased Benefits From Cryopreservation
                    5.2.2.3 Regulations and Laws for Ethical use of Animals in Research
                               5.2.2.3.1 the Animal Welfare Act
                               5.2.2.3.2 Public Health Service Policy on Humane Care and use of Laboratory Animals
           5.2.3 Opportunities
                    5.2.3.1 Emergence of Crispr as a Powerful Tool in the Field of BioMedical Research
                    5.2.3.2 Rising Demand for Humanized Mice Models
                    5.2.3.3 Increase in Monoclonal Antibody Production
           5.2.4 Challenges
                    5.2.4.1 Development of Alternative Methods to Animal Testing
                    5.2.4.2 Advancements in Zebrafish Model Development
                    5.2.4.3 Growing Need for Improved Mice Models

6 Regulatory Assessment
    6.1 Introduction
    6.2 North America
    6.3 Europe
    6.4 China
    6.5 Japan
    6.6 India
    6.7 Australia
    6.8 Brazil

7 Clinical Studies Assessment
    7.1 Introduction
    7.2 Clinical Studies
    7.3 Clinical Studies Assessment

8 Mice Model Market, By Type
    8.1 Introduction
    8.2 Inbred Mice
    8.3 Outbred Mice
    8.4 Genetically Engineered Mice
    8.5 Hybrid/Congenic Mice
    8.6 Conditioned/Surgically Modified Mice
    8.7 Spontaneous Mutant Mice

9 Mice Model Market, By Service
    9.1 Introduction
    9.2 Breeding
    9.3 Cryopreservation
    9.4 Quarantine
    9.5 Rederivation
    9.6 Model In-Licensing
    9.7 Genetic Testing
    9.8 Other Services

10 Mice Model Market, By Technology
     10.1 Introduction
     10.2 Crispr/Cas9
     10.3 Microinjection
     10.4 Embryonic Stem Cell Injection
     10.5 Nuclear Transfer
     10.6 Other Technologies
             10.6.1 Genetically Modified Sperm-Mediated Gene Transfer
             10.6.2 Virus/Vector-Mediated Gene Transfer
             10.6.3 Liposome-Mediated DNA and Electroporation of DNA
             10.6.4 Biolistics
             10.6.5 Talens and Zfns

11 Mice Model Market, By Application
     11.1 Introduction
     11.2 Oncology Studies
     11.3 Immunology and Inflammation Studies
     11.4 Diabetes Studies
     11.5 Cardiovascular Studies
     11.6 Central Nervous System (Cns) Studies
     11.7 Other Disease Studies

12 Mice Care Products Market, By Type
     12.1 Introduction
     12.2 Cages
     12.3 Feed
     12.4 Bedding
     12.5 Other Care Products

13 Mice Model Market, By Region
     13.1 Introduction
     13.2 North America
             13.2.1 U.S.
             13.2.2 Canada
     13.3 Europe
             13.3.1 Germany
             13.3.2 U.K.
             13.3.3 France
             13.3.4 Itally
             13.3.5 Spain
             13.3.6 Rest of Europe (RoE)
     13.4 Asia-Pacific
             13.4.1 China
             13.4.2 Japan
             13.4.3 India
             13.4.4 Rest of Asia-Pacific (RoAPAC)
     13.5 Rest of the World (RoW)
             13.5.1 Latin America
             13.5.2 Middle East & Africa

14 Competitive Landscape
     14.1 Overview
     14.2 Mice Model Market: Market Share Analysis (2018)
     14.3 Competitive Situation and Trends
             14.3.1 Alliances, Collaborations, Agreements, Partnerships, and Joint Ventures
             14.3.2 Grants & Funds
             14.3.3 Expansions
             14.3.4 Product Launches
             14.3.5 Acquisitions
             14.3.6 Licensing
             14.3.7 Others

15 Company Profiles (20 Companies Will be Profiled)
(Overview, Products and Services, Financials & Development) *
     15.1 Introduction
     15.2 Charles River Laboratories International, Inc.
             15.2.1 Business Overview
             15.2.2 Products and Services Offered
             15.2.3 Recent Developments
             15.2.4 MnM View
     15.3 The Jackson Laboratory
             15.3.1 Business Overview
             15.3.2 Products and Services Offered
             15.3.3 Recent Developments
             15.3.4 MnM View
     15.4 Taconic Biosciences, Inc.
             15.4.1 Business Overview
             15.4.2 Products and Services Offered
             15.4.3 Recent Developments
             15.4.4 MnM View
     15.5 Envigo
             15.5.1 Business Overview
             15.5.2 Products and Services Offered
             15.5.3 Recent Developments
             15.5.4 MnM View
     15.6 Laboratory Corporation of America Holdings
               15.6.1  Business Overview
              15.6.2 Products and Services Offered
               15.6.3  Recent Developments
     15.7 JANVIER LABS
             15.7.1 Business Overview
             15.7.2 Products and Services Offered
             15.7.3 Recent Developments
     15.8 Harbour Antibodies Bv (A Subsidiary of Harbour BioMed)
             15.8.1 Business Overview
             15.8.2 Products and Services Offered
             15.8.3 Recent Developments
     15.9 Trans Genic, Inc.
             15.9.1 Business Overview
             15.9.2  Products and Services Offered
             15.9.3 Recent Developments
     15.10 genOway
               15.10.1 Business Overview
               15.10.2 Products and Services Offered
               15.10.3 Recent Developments
     15.11 Horizon Discovery Group PLC (Sage Labs, Inc.)
               15.11.1 Business Overview 
               15.11.2 Products and Services Offered
               15.11.3 Recent Developments
     15.12 Ingenious Targeting Laboratory
               15.12.1  Business Overview
               15.12.2 Products and Services Offered
               15.12.3 Recent Developments
     15.13 Polygene
               15.13.1 Business Overview
               15.13.2  Products and Services Offered
               15.13.3  Recent Developments
     15.14 Aragen
               15.14.1   Business Overview
               15.14.2  Products and Services Offered
               15.14.3  Recent Developments
     15.15 Ozgene Pty Ltd.
               15.15.1   Business Overview
               15.15.2   Products and Services Offered
                15.15.3  Recent Developments
     15.16 Transcure Bioservices
               15.16.1  Business Overview
               15.16.2  Products and Services Offered
               15.16.3  Recent Developments
     15.17 Crown Bioscience Inc.   
               15.17.1  Business Overview
               15.17.2   Products and Services Offered
               15.17.3  Recent Developments
     15.18  German Mouse Clinic
               15.18.1 Business Overview
               15.18.2   Products and Services Offered
               15.18.3  Recent Developments
     15.19 C&M Labpro, LLC
               15.19.1  Business Overview
               15.19.2  Products and Services Offered
               15.19.3  Recent Developments
     15.20 SCL 
               15.20.1  Business Overview
               15.2o.2   Products and Services Offered
               15.20.3  Recent Developments

16 Appendix
     16.1  Discussion Guide
     16.2 Other Developments 
     16.3  Knowledge Store: Marketsandmarkets’ Subscription Portal
     16.4 Introducing Rt: Real-Time Market Intelligence
     16.5  Available Customizations
     16.6 Related Reports
     16.7  Author Details


List of Tables (116 Tables)

Table 1 Sampling Frame: Primary Research
Table 2 Indicative List of Clinical Studies Conducted Using Mice Models
Table 3 Global Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 4 Inbred Mice Model Market Size, By Country, 2014–2021 (USD Million)
Table 5 Outbred Mice Model Market Size, By Country, 2014–2021 (USD Million)
Table 6 Genetically Engineered Mice (Knockout/Knockin) Model Market Size, By Country, 2014–2021 (USD Million)
Table 7 Hybrid/Congenic Mice Model Market Size, By Country, 2014–2021 (USD Million)
Table 8 Conditioned/Surgically Modified Mice Model Market Size, By Country, 2014–2021 (USD Million)
Table 9 Spontaneous Mutant Mice Model Market Size, By Country, 2014–2021 (USD Million)
Table 10 Global Mice Model Market Size, By Service, 2014–2021 (USD Million)
Table 11 Breeding Services Market Size, By Country, 2014–2021 (USD Million)
Table 12 Cryopreservation Services Market Size, By Country, 2014–2021 (USD Million)
Table 13 Quarantine Services Market Size, By Country, 2014–2021 (USD Million)
Table 14 Rederivation Services Market Size, By Country, 2014–2021 (USD Million)
Table 15 Model in Licensing Services Market Size, By Country, 2014–2021 (USD Million)
Table 16 Genetic Testing Services Market Size, By Country, 2014–2021 (USD Thousand)
Table 17 Other Services Market Size, By Country, 2014–2021 (USD Thousand)
Table 18 Global Mice Model Market, By Technology, 2014–2021 (USD Million)
Table 19 Mice Model Market Size for Crispr, By Country, 2014–2021 (USD Million)
Table 20 Mice Model Market Size for Microinjection, By Country, 2014–2021 (USD Million)
Table 21 Mice Model Market Size for Embryonic Stem Cell Injection, By Country, 2014–2021 (USD Thousand)
Table 22 Mice Model Market Size for Nuclear Transfer, By Country, 2014–2021 (USD Thousand)
Table 23 Mice Model Market Size for Other Technologies, By Country, 2014–2021 (USD Thousand)
Table 24 Global Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 25 Indicative List of Recent Cancer Research Studies Using Mice Models
Table 26 Mice Model Market Size for Oncology Studies, By Country/Region, 2014–2021 (USD Million)
Table 27 Mice Model Market Size for Immunology and Inflammation Studies, By Country/Region, 2014–2021 (USD Million)
Table 28 Mice Model Market Size for Diabetes Studies, By Country/Region, 2014–2021 (USD Million)
Table 29 Mice Model Market Size for Cardiovascular Studies, By Country/Region, 2014–2021 (USD Million)
Table 30 Recent CNS Disorder-Related Research Studies Using Mice Models
Table 31 Mice Model Market Size for CNS Studies, By Country/Region, 2014–2021 (USD Million)
Table 32 Mice Model Market Size for Other Disease Studies, By Country/Region, 2014–2021 (USD Million)
Table 33 Global Mice Care Products Market Size, By Type, 2014–2021 (USD Million)
Table 34 Mice Cages Market Size, By Region, 2014–2021 (USD Thousand)
Table 35 Mice Feed Market Size, By Region, 2014–2021 (USD Thousand)
Table 36 Mice Bedding Market Size, By Region, 2014–2021 (USD Thousand)
Table 37 Other Mice Care Products Market Size, By Region, 2014–2021 (USD Thousand)
Table 38 Global Mice Model Market Size, By Region, 2014–2021 (USD Million)
Table 39 North America: Mice Model Market Size, By Country, 2014–2021 (USD Million)
Table 40 North America: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 41 North America: Mice Model Market Size, By Technology, 2014–2021 (USD Million)
Table 42 North America: Mice Model Market Size, By Service, 2014–2021 (USD Million)
Table 43 North America: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 44 North America: Mice Model Market Size, By Care Product, 2014–2021 (USD Million)
Table 45 NIH Funding for Projects Related to Animal Models
Table 46 Associations Directly Related to the Animal Model Market
Table 47 Associations Indirectly Related to the Animal Model Market
Table 48 U.S.: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 49 U.S.: Mice Model Market Size, By Technology, 2014–2021 (USD Million)
Table 50 U.S.: Mice Model Market Size, By Service, 2014–2021 (USD Million)
Table 51 U.S.: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 52 Canada: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 53 Canada: Mice Model Market Size, By Technology, 2014–2021 (USD Thousand)
Table 54 Canada: Mice Model Market Size, By Service, 2014–2021 (USD Thousand)
Table 55 Canada: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 56 Europe: Mice Model Market Size, By Country, 2014–2021 (USD Million)
Table 57 Europe: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 58 Europe: Mice Model Market Size, By Technology, 2014–2021 (USD Million)
Table 59 Europe: Mice Model Market Size, By Service, 2014–2021 (USD Million)
Table 60 Europe: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 61 Europe: Mice Model Market Size, By Care Product, 2014–2021 (USD Thousand)
Table 62 Germany: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 63 Germany: Mice Model Market Size, By Technology, 2014–2021 (USD Million)
Table 64 Germany: Mice Model Market Size, By Service, 2014–2021 (USD Million)
Table 65 Germany: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 66 U.K.: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 67 U.K.: Mice Model Market Size, By Technology, 2014–2021 (USD Million)
Table 68 U.K.: Mice Model Market Size, By Service, 2014–2021 (USD Million)
Table 69 U.K.: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 70 France: Mice Model Market Size, By Type, 2014–2021 (USD Thousand)
Table 71 France: Mice Model Market Size, By Technology, 2014–2021 (USD Thousand)
Table 72 France: Mice Model Market Size, By Service, 2014–2021 (USD Thousand)
Table 73 France: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 74 European Animal Care Associations and Their Events
Table 75 Pharma 2020: Implementation
Table 76 RoE: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 77 RoE: Mice Model Market Size, By Technology, 2014–2021 (USD Million)
Table 78 RoE: Mice Model Market Size, By Service, 2014–2021 (USD Thousand)
Table 79 RoE: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 80 Asia-Pacific: Mice Model Market Size, By Country, 2014–2021 (USD Million)
Table 81 Asia-Pacific: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 82 Asia-Pacific: Mice Model Market Size, By Technology, 2014–2021 (USD Thousand)
Table 83 Asia-Pacific: Mice Model Market Size, By Service, 2014–2021 (USD Million)
Table 84 Asia-Pacific: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 85 Asia-Pacific: Mice Model Market Size, By Care Product, 2014–2021 (USD Thousand)
Table 86 China: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 87 China: Mice Model Market Size, By Technology, 2014–2021 (USD Thousand)
Table 88 China: Mice Model Market Size, By Service, 2014–2021 (USD Thousand)
Table 89 China: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 90 Japan: Significant Partnerships
Table 91 Japan: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 92 Japan: Mice Model Market Size, By Technology, 2014–2021 (USD Thousand)
Table 93 Japan: Mice Model Market Size, By Service, 2014–2021 (USD Thousand)
Table 94 Japan: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 95 Study Results Regarding R&D Expenditure of 25 Pharmaceutical Companies
Table 96 India: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 97 India: Mice Model Market Size, By Technology, 2014–2021 (USD Thousand)
Table 98 India: Mice Model Market Size, By Service, 2014–2021 (USD Thousand)
Table 99 India: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 100 RoAPAC: Player Activity, 2013 to 2015
Table 101 RoAPAC: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 102 RoAPAC: Mice Model Market Size, By Technology, 2014–2021 (USD Thousand)
Table 103 RoAPAC: Mice Model Market Size, By Service, 2014–2021 (USD Thousand)
Table 104 RoAPAC: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 105 RoW: Mice Model Market Size, By Type, 2014–2021 (USD Thousand)
Table 106 RoW: Mice Model Market Size, By Technology, 2014–2021 (USD Thousand)
Table 107 RoW: Mice Model Market Size, By Service, 2014–2021 (USD Thousand)
Table 108 RoW: Mice Model Market Size, By Application, 2014–2021 (USD Thousand)
Table 109 RoW: Mice Model Market Size, By Care Product, 2014–2021 (USD Thousand)
Table 110 Alliances, Collaborations, Agreements, Joint Ventures, and Partnerships (2013–2016)
Table 111 Grants & Funds, 2013–2016
Table 112 Key Players Focusing on Expansions (2013–2016)
Table 113 Product Launches (2013–2016)
Table 114 Acquisitions (2013–2016)
Table 115 Licensing (2013–2016)
Table 116 Key Players Focusing on Other Strategies (2013–2016)
 
 
List of Figures (46 Figures)
 
Figure 1 Global Mice Model Market: Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Market Forecast Design
Figure 6 Data Triangulation Methodology
Figure 7 Global Mice Model Market, By Technology (2016 Vs. 2021)
Figure 8 Global Mice Model Market, By Type (2016 Vs. 2021)
Figure 9 Global Mice Model Market, By Service (2016 Vs. 2021)
Figure 10 Global Mice Model Market, By Application (2016 Vs. 2021)
Figure 11 Global Mice Care Products Market, By Type (2016 Vs. 2021)
Figure 12 Asia-Pacific to Register the Highest Growth During the Forecast Period
Figure 13 Growing Pharma R&D and Increasing Funding are Expected to Drive the Global Mice Model Market During the Forecast Period
Figure 14 North America to Dominate the Mice Care Products Market in 2016
Figure 15 Crispr to Account for the Largest Share of the Global Mice Model Market, By Technology
Figure 16 Asia-Pacific to Register the Highest Growth in the Global Mice Model Market From 2016 to 2021
Figure 17 Mice Model Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Clinical Studies Using Mice Models, By Indication (2013 Onwards)
Figure 19 Clinical Studies Using Mice Models, By Completion (2013 Onwards)
Figure 20 Clinical Studies Completion Estimates Per Year (2014–2022)
Figure 21 Genetically Engineered Mice to be the Fastest-Growing Mice Model Market Segment During the Forecast Period
Figure 22 Breeding Services Accounted for the Largest Share of the Mice Model Market in 2016
Figure 23 Crispr Technology Segment to Dominate the Mice Model Technology Market in 2016
Figure 24 Oncology to Dominate the Mice Model Market in 2016
Figure 25 Cages Accounted for the Largest Share of the Mice Care Products Market in 2016
Figure 26 Asia-Pacific to Grow at the Highest CAGR in the Mice Model Market During the Forecast Period
Figure 27 North America: Mice Model Market Snapshot
Figure 28 Germany to Dominate the European Mice Model Market in 2016
Figure 29 Number of Cell Therapy Preclinical Studies Listed in the Preclinical Research Database in the U.K., 2013–2016
Figure 30 China: the Fastest-Growing Country in the Asia-Pacific Mice Model Market During the Forecast Period
Figure 31 Oncology Studies to Dominate the RoW Mice Model Market, By Application
Figure 32 Major Players Focused on Inorganic Growth Strategies (2013-2016)
Figure 33 Global Mice Model Market Share, By Key Player, 2015
Figure 34 Battle for Market Share: Alliances, Agreements, Collaborations, Joint Ventures, and Partnerships Formed the Key Growth Strategy
Figure 35 Alliances, Collaborations, Agreements, Joint Ventures, and Partnerships (2013–2016), By Company
Figure 36 Key Players Focusing on Grants & Funds (2013-2016)
Figure 37 Key Players Focusing on Expansions (2013-2016)
Figure 38 Key Players Focusing on Product Launches (2013-2016)
Figure 39 Key Players Focusing on Acquisitions (2013-2016)
Figure 40 Key Players Focusing on Licensing (2013-2016)
Figure 41 Key Players Focusing on Other Strategies (2013-2016)
Figure 42 Business Focus of the Top 3 Market Players
Figure 43 Charles River Laboratories International, Inc.: Company Snapshot (2015)
Figure 44 The Jackson Laboratory: Company Snapshot (2015)
Figure 45 Laboratory Corporation of America Holdings: Company Snapshot (2015)
Figure 46 Trans Genic, Inc.: Company Snapshot (2015)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 2192
Published ON
Feb, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Mice Model Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home